Initial trial

Study / Research

A trial that tested the effect of a PCSK9 inhibitor on patients with Lp(a), showing a small reduction of approximately 15% in Lp(a) levels.

Mentioned in 1 video

Videos Mentioning Initial trial

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A trial that tested the effect of a PCSK9 inhibitor on patients with Lp(a), showing a small reduction of approximately 15% in Lp(a) levels.